Pancreatic cancer is a highly malignant digestive system tumor, mainly occurring in middle-aged and elderly people. The timeliness and scientific nature of treatment determine patient prognosis. Missing early treatment makes the tumor prone to spreading and metastasis, significantly reducing survival rates. Multiple treatment methods are currently available, and combining them can effectively control the disease.
Immune reconstruction cell therapy enhances and regulates the patient’s own immune system, improving the recognition and killing of tumor cells, offering hope for better outcomes in pancreatic cancer patients. Its advantages include:
① Strong targeting ability, reducing damage to normal tissues;
② Long-term maintenance of immune surveillance;
③ Synergy with traditional therapies to improve overall efficacy. This therapy has achieved positive progress at United Life International Medical Center, bringing new hope to patients.
During actual treatment, cancer patients undergoing surgery, radiotherapy, and chemotherapy often face impaired immune function, increased infection risks, and slow recovery. To help patients better tolerate treatment and improve survival quality, it is necessary to scientifically formulate phased immune reconstruction plans for different treatment cycles.
● Short-term Plan: Rapidly enhance immunity through immune cell reinfusion, boosting the effectiveness of anti-cancer treatment.
● Mid-term Plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.
● Long-term Plan: Enhance overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby improving quality of life and extending survival.
1. Surgical Treatment
Surgery is the main curative approach for pancreatic cancer, especially suitable for early and localized lesions. Common procedures include pancreaticoduodenectomy and total pancreatectomy. Surgery can remove tumors and surrounding affected tissues, helping prolong survival. However, recovery takes longer, and many patients cannot undergo surgery due to late-stage disease.
2. Chemotherapy and Radiotherapy
Chemotherapy is an important part of pancreatic cancer treatment, mainly for postoperative adjuvant therapy and late-stage disease control. Common drugs include gemcitabine, which can slow tumor progression. Radiotherapy is often used for local control and symptom relief. Chemotherapy and radiotherapy can be combined to enhance efficacy, relieve pain, and address complications.
3. Minimally Invasive Treatments
With technological advances, minimally invasive surgeries such as laparoscopic pancreatectomy are increasingly used, reducing surgical trauma and speeding up recovery. Additionally, local ablation and interventional treatments such as radioactive seed implantation and transarterial chemoembolization are applied in pancreatic cancer treatment, suitable for patients unable to tolerate major surgery.
4. Targeted Therapy
Targeted therapy blocks cancer cell growth signals by focusing on specific molecules. Although still in the developmental stage, some drugs have shown potential, making it an important future treatment direction.
5. Irreversible Electroporation (NanoKnife)
Under CT guidance, electrode needles are inserted percutaneously, and high-voltage pulses break tumor cell membranes. This technique treats locally advanced pancreatic cancer without damaging blood vessels or bile ducts.
6. Interventional Arterial Infusion Chemotherapy
A catheter is inserted from the femoral artery into the pancreatic artery to continuously infuse high-concentration chemotherapy drugs such as gemcitabine. This method increases local drug concentration by 8 times, controlling late-stage tumor progression.
Pancreatic cancer treatment requires multidisciplinary collaboration, combining surgery, chemotherapy, radiotherapy, immune reconstruction cell therapy, and minimally invasive techniques. Experts at United Life International Medical Center emphasize that individualized precision treatment plans are essential to improving survival and quality of life. Early diagnosis and timely treatment are key to better prognosis.